Breathe Well Live Well
|
FDA Panel to Vote on Approval, Dosing for COPD Drug
MedPage Today But, the "major safety issue with indacaterol is linked to selection of appropriate dose, because beta-adrenergic agonist bronchodilators, particularly at high doses, have the safety concern of severe asthma exacerbations and asthma related deaths in … |
View full post on asthma – Google News
|
Lotus Pharmaceuticals, Inc. (LTUS) Receives Phase I Approval for Asthma Drug
International Business Times Lotus Pharmaceuticals, Inc. said that research conducted by a third party indicated that the Asthma market in China is approximately $300 million annually, … Lotus Pharmaceuticals Receives SFDA Approval to Initiate Phase I Clinical … |
View full post on asthma – Google News
|
Lotus Pharmaceuticals Receives SFDA Approval to Initiate Phase I Clinical …
PR Newswire (press release) According to IMS Health, a pharmaceutical market research firm, the anti-asthma and chronic obstructive pulmonary disease market in China reached … |
View full post on asthma – Google News
 TopNews Arab Emirates |
US approval for Pharmaxis asthma test
Sydney Morning Herald PHARMAXIS, which develops treatments for respiratory and autoimmune diseases, has won regulatory approval to sell its asthma test kit, Aridol, in the US. … US approval proves a shot in the arm Pharmaxis gets the right news at the right time US Food and Drug Administration Approves Aridol |
View full post on asthma – Google News
|
N30 Pharma Announces FDA Approval to Initiate Phase 1 Clinical Trial for First …
PR Newswire (press release) It is the lead product in N30 Pharma's portfolio of drugs which are designed to treat asthma, COPD and IBD. N6022 will initially be tested using intravenous … |
View full post on asthma – Google News
New system to help asthmatics gets approval by FDA
People with severe asthma are getting a radically different treatment option: A way to snake a wire inside their lungs and melt off some of the tissue that squeezes their airways shut.But the Alair system, rolling out this month, offers the first method of altering spasm-prone airways.”It does seem to improve your ability to live with your asthma,” says Dr. Michael Silver of Chicago’s Rush …
Read more on Chicago Sun-Times